Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
What disease - BTK gene defect, what type of gene?
|
Bruton's agammaglobulinemia - tyrosine kinase gene
|
|
Inheritance pattern of Bruton's agammaglobulinemia
|
X-linked recessive
|
|
When does disease start to show up in Bruton's?
|
recurrent bacterial infections after 6 months of age - when levels of maternal IgG Ab decline
|
|
3 common causes of SCID
|
failure to synthesize MHC II antigens, defective IL-2 receptors, adenosine deaminase deficiency
|
|
What occurs with IL-12 receptor deficiency
|
Disseminated mycobacterial infection due to decreased Th1 response and macrophages cannot be activated to form granulomas
|
|
Defect in CD40 ligand on CD4 T helper cells.
|
Hyper-IgM syndrome. Inability to class switch. High levels of IgM; very low levels of IgG, IgA, and IgE
|
|
Hyper-IgM syndrome: pathophys
|
Defect in CD40 ligand on CD4 T helper cells leading to inability to class switch
|
|
Wiskott-Aldrich syndrome: pathophys
|
X-linked defect in ability to mount an IgM response to capsular polysaccharides of bacteria
|
|
X-linked defect in ability to mount an IgM response to capsular polysaccharides of bacteria
|
Wiskott-Aldrich syndrome
|
|
Ig levels in Wiskott-Aldrich
|
Low IgM. Elevated IgE and IgA
|
|
Pathophys of Job's syndome (Hyper IgE syndrome)
|
Failure of IFN-gamma production by Th1; Neutrophils fail to respond to chemotactic stimuli\
|
|
Clinical presentation of Job's syndrome
|
coarse Facies, cold (noninflammed) staph Abscesses, retained primary Teeth, Inc IgE, and Dermatologic problems (eczema) (FATED)
|
|
Triad of symptoms associated with Wiskoff Aldrich syndrome
|
pyogenic infections, thrombocytopenic purpura, eczema (WIPE)
|
|
Pathophys of Leukocyte adhesion deficiency syndrome (type I)
|
Defect in LFA-1 integrin (CD18) proteins on phagocytes.
|
|
Presents early with recurrent bacterial infections, absent pus formation, neutrophilia, and delayed separation of umbilicus
|
Leukocyte adhesion deficiency syndrome (type 1)
|
|
Recurrent pyogenic infections by staph and strept, partial albinism, and peripheral neuropathy
|
Chediak-Higashi syndrome
|
|
Pathophys of Chediak-Higashi syndrome
|
Autosomal recessive. Defect in microtubular fx and lysosomal emptying of phagocytic cells
|
|
Pathophys of Chronic Granulomatous disease
|
Defect in microbicidal activity of neutrophils owing to lack of NADPH oxidase activity or similar enzymes.
|
|
Chronic granulomatous disease presentation
|
Marked susceptibility to opportunistic infections with bacteria: esp S. aureus and E.coli as well as Aspergillus
|
|
Dx of chronic granulomatous disease confirmed how?
|
NEGATIVE nitroblue tetrazolium dye reduction test
|
|
Pathophys of chronic mucocutaneous candidiasis
|
Idiopathic dysfx of T cells. T cell dysfx especially against Candida albicans. Presents with skin and mucous membrane Candida infectins
|
|
Most common selective Ig deficiency
|
IgA deficiency
|
|
Presentation of selective IgA deficiency
|
Sinus and lung infections; milk allergies and diarrhea common. Anaphylaxis upon exposure to blood products containing IgA
|
|
Pathophys of ataxia-telangiectasia
|
Mutation in ATM gene which codes for a protein kinase inovlved in signaling pathways for DNA repair enzymes. Asocciated with IgA deficiency.
|
|
Cerebellar problems, spider angiomas, associated with IgA deficiency
|
Ataxia-telangiectasia
|
|
Pathophys of common variable immunodeficiency (CVID)
|
Normal numbers of circulating B cells, decreased plasma cells (defect in B-cell maturation), decreased Ig, can be acuired in 20s -30s.
|
|
What does common variable immunodeficiency put one at an increased risk of
|
Autioimmune disease and lymphoma
|
|
Antihistone Ab
|
Drug induced lupus
|
|
Antiendomysial Ab
|
Celiac disease
|
|
Anti-desmoglein Ab
|
Pemphigus vulgaris
|
|
Anti-Jo-1 Ab
|
Polymositis, dermatomyositis
|
|
Autoantibody of Celiac disease
|
Antigliadin, antiendomysial
|
|
Antibody assoc with Pemphigus vulgaris
|
Anti-desmoglein
|
|
Antibody associated with polymyositis and dermatomyositis
|
Anti-Jo1-1
|
|
Autoantibody assoc with mixed connective tissue disease
|
Anti-U1 RNP (ribonucleoprotein)
|
|
Anti-smooth muscle
|
Autoimmune hepatitis
|
|
Ab assoc with autoimmune hepatitis
|
Anti-smooth muscle
|
|
Anti-glutamate decarboxylase: disease
|
Type 1 DM
|
|
Disease assoc with HLA-A3
|
Hemochromatosis
|
|
HLA subtype: hemochromatosis
|
HLA-A3
|
|
4 disease: HLA-B27
|
Psoriasis, Ankylosing spondylitis, Inflammatory bowel disease, Reiter's syndrome
|
|
HLA-DR2 - 4 disease
|
MS, hay fever, SLE, Goodpasture's
|
|
HLA-DR3 - 2 disease
|
DM type 1, Graves
|
|
HLA-DR4: 2 disease
|
DM type 1, RA
|
|
HLA-DR5: 2 disease
|
Pernicious anemia, Hashimoto's thyroiditis
|
|
HLA-DR7: 1 disease
|
Steroid responsive nephrotic syndrome (minimal change)
|
|
Anticentromere Ab
|
Scleroderma (CREST)
|
|
Difference between hyperacute and acute rejection of transplant
|
Hyperacute: ab mediated due to preformed antidonor Ab - within minutes. Acute : cell mediated due to cytotoxic T lymphocytes - weeks after transplantation
|
|
Pathophys of chronic rejection of transplant
|
T cell and Ab mediated vascular damage (obliterative vascular fibrosis) occurs months to years after transplantation. irreversible. Class I-MHC non self is perceived by CTLs as class I-MHC self presenting a non-self Ag
|
|
Maculopapular rash, jaundice, hepatosplenomegaly, and diarrhea after transplant procedure
|
Graft-versus-host disease
|
|
Toxicity of cyclosporine
|
Predisposes patients to viral infections and lymphoma; nephrotoxic (preventable with mannitol diuresis)
|
|
Mechanism of cyclosporine
|
Binds to cyclophilins. Complex blocks differentiation and activation of T cells by inhibiting calcineurin, cytoplasmic phosphatase necessary for activation of T cell specific transcription factor: NF-AT which is involved in production of IL-2 and its receptor
|
|
Mechanism of Tacrolimus (FK506)
|
Similar to cyclosporine; binds to FK-binding protein, inhibiting calcineurin.
|
|
Toxicities of Tacrolimus
|
Significant toxicity - nephrotoxicity, peripheral neuropathy, HTN, pleural effusion, hyperglycemia
|
|
Azathioprine: mechanism
|
Precursor to 6-mercaptopurine / PURINE ANALOG that interfers with metabolism and synthesis of nucleic acids. Toxic to proliferating lymphocytes.
|
|
toxicity of Azathioprine
|
Bone marrow suppression. Mercaptopurine is metabolized by xanthine oxidase so allopurinol increases toxic effects
|
|
Mechanism of Muromonab-CD3 (OKT3)
|
Monoclonal antibody that binds to CD3 on surface of T cells blocking interaction with CD3 protein that is responsible for T cell signal transduction
|
|
Toxicities of Muromonab-CD3
|
Cytokine release syndrome (Abs bind to T cell receptor and activate T cells before they are destroyed), hypersensitivity rxn
|
|
Mechanism of Sirolimus
|
Binds to mTOR (mammalian target of rapamycin) that inhibits T cell proliferation in response to IL-2
|
|
3 toxicities of Sirolimus
|
Hyperlipidemia, thrombocytopenia, leukopenia
|
|
Mechanism of Mycophenolate mofetil
|
Inhibits de novo guanine synthesis and blocks lymphocyte production
|
|
Mechanism of Daclizumab
|
Monoclonal Ab with high affinity for IL-2 receptor on activated T cells
|
|
Aldesleukin: what is it?
|
IL-2 recombinant ck, used for Renal cell carcinoma, metastatic melanoma
|
|
What 2 agents are used for recovery of bone marrow - granulocytes
|
Filgrastim (G-CSF) and Sargramostim (GM-CSF)
|
|
IFN-a is used for what five diseases
|
Hep B and C, Kaposi's sarcoma, leukemias, malignant melanoma
|
|
IFN-b is used for what disease
|
Multiple sclerosis
|
|
IFN-gamma is used for what 2 disease
|
Chronic granulomatous disease or IL-12 receptor deficiency
|
|
What is used for thrombocytopenia?
|
Oprelevekin (IL-11, megakaryocyte GF)
|
|
Oprelevkin: what is it?
|
IL-11 - megakaryocyte growth factor used for thrombocytopenia
|